6 Apr
2020

Cannabis legislation opens the door for pharmaceutical brands in Latin America

With new legislation regulating the use of cannabis-based medicines in Argentina and Brazil, the emerging market is an open playing field for pharmaceutical brands looking to make their mark in Latin America.

Daniela Lin

Director

H&A, Brazil

[email protected]

Guillermo Alcaraz

Head of the trademark department

H&A, Argentina

[email protected]

TAGS

Brand management, Government/Policy, Portfolio Management, Trademark law, Food and Beverage, Pharmaceuticals, Argentina, Brazil, Latin America & Caribbean